<p>Maximus, Inc.（纽约证券交易所代码：MMS - 免费报告）- Zacks Research 的股票研究分析师在 12 月 11 日星期四发布的报告中发布了对 Maximus 的 2028 财年每股收益（EPS）预期。Zacks Research 分析师团队预计该健康服务提供商将在该年度每股收益为 8.95 美元。Zacks Research 目前对该股票的评级为 “持有”。Maximus 当前全年的共识收益预期为每股 6.15 美元。</p>
<p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）最近于 11 月 20 日星期四发布了其财报。该健康服务提供商报告季度每股收益（EPS）为 1.62 美元，低于分析师共识预期的 1.63 美元，差额为 0.01 美元。该公司在本季度的收入为 13.2 亿美元，而共识预期为 13.4 亿美元。Maximus 的净利润率为 5.87%，股本回报率为 25.23%。该公司的收入同比增长 0.2%。在去年同期，该公司每股收益为 1.46 美元。Maximus 已将其 2026 财年的指导目标设定为每股收益 7.950-8.250。</p>
<p>另外，Weiss Ratings 在 12 月 8 日星期一的研究报告中重申了对 Maximus 股票的 “买入（b-）” 评级。两位分析师对该股票给予了买入评级，一位分析师给予了持有评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，平均目标价格为 90.00 美元。</p>
<p><strong>阅读我们最新的 MMS 研究报告</strong></p>
<h2>Maximus 股价下跌 0.8%</h2>
<p>Maximus 股票在星期一开盘价为 84.33 美元。该公司的 50 日移动平均线为 84.72 美元，200 日移动平均线为 80.79 美元。该公司的市值为 45.9 亿美元，市盈率为 15.17，贝塔值为 0.56。Maximus 的一年低点为 63.77 美元，一年高点为 92.50 美元。该公司的流动比率为 1.64，速动比率为 1.64，债务与股本比率为 0.77。</p>
<h2>Maximus 的机构交易</h2>
<p>几家机构投资者最近增加或减少了对该股票的持股。Dimensional Fund Advisors LP 在第三季度将其在 Maximus 的持股增加了 2.0%。Dimensional Fund Advisors LP 目前拥有 1,869,573 股该健康服务提供商的股票，价值 1.70812 亿美元，此前在该期间购买了额外的 36,989 股。Fuller &amp; Thaler Asset Management Inc. 在第一季度将其在 Maximus 的持股增加了 40.0%。Fuller &amp; Thaler Asset Management Inc. 目前拥有 1,729,305 股该健康服务提供商的股票，价值 1.17921 亿美元，此前在该期间购买了额外的 494,372 股。AQR Capital Management LLC 在第一季度将其在 Maximus 的持股增加了 177.2%。AQR Capital Management LLC 目前拥有 1,173,329 股该健康服务提供商的股票，价值 7934.1 万美元，此前在上个季度购买了额外的 750,031 股。Boston Partners 在第三季度将其在 Maximus 的持股增加了 47.0%。Boston Partners 目前拥有 966,139 股该健康服务提供商的股票，价值 8823.6 万美元，此前在该期间购买了额外的 308,892 股。最后，Reinhart Partners LLC 在第三季度将其在 Maximus 的持股增加了 0.8%。Reinhart Partners LLC 目前拥有 921,578 股该健康服务提供商的股票，价值 8420.6 万美元，此前在上个季度购买了额外的 7,722 股。97.21% 的股票目前由机构投资者持有。</p>
<h2>内部买卖</h2>
<p>在其他 Maximus 的新闻中，内部人士 Michelle F. Link 于 12 月 3 日星期三出售了 4,039 股该公司的股票。该股票以平均价格 86.84 美元出售，总交易额为 350,746.76 美元。出售后，该内部人士直接持有 19,542 股公司的股票，价值 1,697,027.28 美元。此次交易使其持股减少了 17.13%。该交易已在与 SEC 的法律文件中披露，您可以通过此链接访问。1.60% 的股票目前由公司内部人士持有。</p>
<h2>Maximus 股息公告</h2>
<p>该公司最近还披露了季度股息，该股息于 12 月 1 日星期一支付。11 月 14 日星期五的登记投资者获得了 0.30 美元的股息。这相当于每年 1.20 美元的股息，收益率为 1.4%。除息日期为 11 月 14 日星期五。Maximus 的股息支付比率（DPR）为 21.58%。</p>
<h2>Maximus 公司简介</h2>
<p>（获取免费报告）</p>
<p>Maximus, Inc. 在美国及国际上作为政府服务提供商运营。它通过三个部门运营：美国联邦服务、美国服务和美国以外的服务。美国服务部门提供项目资格支持和注册；集中式多语言客户联络中心、多渠道和数字自助服务选项；申请协助和独立健康计划选择咨询；受益人外展、教育、资格、注册和重新确定；以及以人为本的独立残疾、长期病和其他健康评估。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 Maximus</li>
<li>如何开始投资于便士股票</li>
<li>Dave &amp; Buster’s 的反转在双底突破后进入了游戏</li>
<li>3 只可以帮助抵御通货膨胀的杂货股票</li>
<li>3 只在 10 年期国债利率上升时值得购买的金融股票</li>
<li>动荡市场中的资产配置策略</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Maximus 吗？</h2>
<p>在考虑 Maximus 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议他们现在购买，以便在更广泛的市场注意到之前……而 Maximus 并不在名单上。</p>
<p>虽然 Maximus 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Zacks Research 预测 Maximus 在 2028 财年的每股收益为 8.95 美元，维持 “持有” 评级。目前的全年每股收益为 6.15 美元。Maximus 报告第四季度每股收益为 1.62 美元，略低于预期。该公司的共识评级为 “适度买入”，目标价格为 90 美元。机构投资者持有 97.21% 的股份。Maximus 最近支付了 0.30 美元的季度股息。内部人士 Michelle F. Link 出售了股份，减少了 17.13% 的持股比例。该公司在美国及国际上提供政府服务</p>

<p>Maximus, Inc. (NYSE:MMS - Free Report) - Equities research analysts at Zacks Research issued their FY2028 earnings per share (EPS) estimates for shares of Maximus in a report issued on Thursday, December 11th. Zacks Research analyst Team anticipates that the health services provider will earn $8.95 per share for the year. Zacks Research currently has a &#34;Hold&#34; rating on the stock. The consensus estimate for Maximus' current full-year earnings is $6.15 per share.</p>
<div class="lb-trans"><p>Maximus, Inc.（纽约证券交易所代码：MMS - 免费报告）- Zacks Research 的股票研究分析师在 12 月 11 日星期四发布的报告中发布了对 Maximus 的 2028 财年每股收益（EPS）预期。Zacks Research 分析师团队预计该健康服务提供商将在该年度每股收益为 8.95 美元。Zacks Research 目前对该股票的评级为 “持有”。Maximus 当前全年的共识收益预期为每股 6.15 美元。</p>
</div><p>Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.01). The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. Maximus had a net margin of 5.87% and a return on equity of 25.23%. The business's revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS.</p>
<div class="lb-trans"><p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）最近于 11 月 20 日星期四发布了其财报。该健康服务提供商报告季度每股收益（EPS）为 1.62 美元，低于分析师共识预期的 1.63 美元，差额为 0.01 美元。该公司在本季度的收入为 13.2 亿美元，而共识预期为 13.4 亿美元。Maximus 的净利润率为 5.87%，股本回报率为 25.23%。该公司的收入同比增长 0.2%。在去年同期，该公司每股收益为 1.46 美元。Maximus 已将其 2026 财年的指导目标设定为每股收益 7.950-8.250。</p>
</div><p>Separately, Weiss Ratings restated a &#34;buy (b-)&#34; rating on shares of Maximus in a research report on Monday, December 8th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $90.00.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 12 月 8 日星期一的研究报告中重申了对 Maximus 股票的 “买入（b-）” 评级。两位分析师对该股票给予了买入评级，一位分析师给予了持有评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，平均目标价格为 90.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on MMS</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 MMS 研究报告</strong></p>
</div><h2>Maximus Trading Down 0.8%</h2>
<div class="lb-trans"><h2>Maximus 股价下跌 0.8%</h2>
</div><p>Shares of Maximus stock opened at $84.33 on Monday. The firm's 50 day moving average is $84.72 and its 200 day moving average is $80.79. The firm has a market capitalization of $4.59 billion, a PE ratio of 15.17 and a beta of 0.56. Maximus has a 1 year low of $63.77 and a 1 year high of $92.50. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77.</p>
<div class="lb-trans"><p>Maximus 股票在星期一开盘价为 84.33 美元。该公司的 50 日移动平均线为 84.72 美元，200 日移动平均线为 80.79 美元。该公司的市值为 45.9 亿美元，市盈率为 15.17，贝塔值为 0.56。Maximus 的一年低点为 63.77 美元，一年高点为 92.50 美元。该公司的流动比率为 1.64，速动比率为 1.64，债务与股本比率为 0.77。</p>
</div><h2>Institutional Trading of Maximus</h2>
<div class="lb-trans"><h2>Maximus 的机构交易</h2>
</div><p>Several institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its position in shares of Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock worth $170,812,000 after purchasing an additional 36,989 shares during the period. Fuller &amp; Thaler Asset Management Inc. lifted its holdings in Maximus by 40.0% in the first quarter. Fuller &amp; Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock valued at $117,921,000 after buying an additional 494,372 shares during the period. AQR Capital Management LLC boosted its position in Maximus by 177.2% during the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider's stock valued at $79,341,000 after acquiring an additional 750,031 shares during the last quarter. Boston Partners grew its holdings in Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after acquiring an additional 308,892 shares during the period. Finally, Reinhart Partners LLC. raised its position in shares of Maximus by 0.8% in the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock worth $84,206,000 after acquiring an additional 7,722 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>几家机构投资者最近增加或减少了对该股票的持股。Dimensional Fund Advisors LP 在第三季度将其在 Maximus 的持股增加了 2.0%。Dimensional Fund Advisors LP 目前拥有 1,869,573 股该健康服务提供商的股票，价值 1.70812 亿美元，此前在该期间购买了额外的 36,989 股。Fuller &amp; Thaler Asset Management Inc. 在第一季度将其在 Maximus 的持股增加了 40.0%。Fuller &amp; Thaler Asset Management Inc. 目前拥有 1,729,305 股该健康服务提供商的股票，价值 1.17921 亿美元，此前在该期间购买了额外的 494,372 股。AQR Capital Management LLC 在第一季度将其在 Maximus 的持股增加了 177.2%。AQR Capital Management LLC 目前拥有 1,173,329 股该健康服务提供商的股票，价值 7934.1 万美元，此前在上个季度购买了额外的 750,031 股。Boston Partners 在第三季度将其在 Maximus 的持股增加了 47.0%。Boston Partners 目前拥有 966,139 股该健康服务提供商的股票，价值 8823.6 万美元，此前在该期间购买了额外的 308,892 股。最后，Reinhart Partners LLC 在第三季度将其在 Maximus 的持股增加了 0.8%。Reinhart Partners LLC 目前拥有 921,578 股该健康服务提供商的股票，价值 8420.6 万美元，此前在上个季度购买了额外的 7,722 股。97.21% 的股票目前由机构投资者持有。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In other Maximus news, insider Michelle F. Link sold 4,039 shares of the business's stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company's stock, valued at $1,697,027.28. The trade was a 17.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Maximus 的新闻中，内部人士 Michelle F. Link 于 12 月 3 日星期三出售了 4,039 股该公司的股票。该股票以平均价格 86.84 美元出售，总交易额为 350,746.76 美元。出售后，该内部人士直接持有 19,542 股公司的股票，价值 1,697,027.28 美元。此次交易使其持股减少了 17.13%。该交易已在与 SEC 的法律文件中披露，您可以通过此链接访问。1.60% 的股票目前由公司内部人士持有。</p>
</div><h2>Maximus Dividend Announcement</h2>
<div class="lb-trans"><h2>Maximus 股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Friday, November 14th. Maximus's dividend payout ratio (DPR) is 21.58%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，该股息于 12 月 1 日星期一支付。11 月 14 日星期五的登记投资者获得了 0.30 美元的股息。这相当于每年 1.20 美元的股息，收益率为 1.4%。除息日期为 11 月 14 日星期五。Maximus 的股息支付比率（DPR）为 21.58%。</p>
</div><h2>Maximus Company Profile</h2>
<div class="lb-trans"><h2>Maximus 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.</p>
<div class="lb-trans"><p>Maximus, Inc. 在美国及国际上作为政府服务提供商运营。它通过三个部门运营：美国联邦服务、美国服务和美国以外的服务。美国服务部门提供项目资格支持和注册；集中式多语言客户联络中心、多渠道和数字自助服务选项；申请协助和独立健康计划选择咨询；受益人外展、教育、资格、注册和重新确定；以及以人为本的独立残疾、长期病和其他健康评估。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Maximus</li>
<li>How to start investing in penny stocks</li>
<li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li>
<li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation</li>
<li>3 Finance Stocks to Buy on Rising 10-Year Treasury Rates</li>
<li>Asset Allocation Strategies in Volatile Markets</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Maximus</li>
<li>如何开始投资于便士股票</li>
<li>Dave &amp; Buster’s 的反转在双底突破后进入了游戏</li>
<li>3 只可以帮助抵御通货膨胀的杂货股票</li>
<li>3 只在 10 年期国债利率上升时值得购买的金融股票</li>
<li>动荡市场中的资产配置策略</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NYSE&amp;Symbol=MMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Maximus Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Maximus 吗？</h2>
</div><p>Before you consider Maximus, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Maximus 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议他们现在购买，以便在更广泛的市场注意到之前……而 Maximus 并不在名单上。</p>
</div><p>While Maximus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Maximus 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Zacks 研究预测 Maximus 的 2028 财年收益（NYSE:MMS）